1. All Products
  2. DINJ - Injectable drugs
  3. MEDROXYPROGESTERONE acetate, 104mg/0.65ml, pref Uniject syr.
Public Pricelist

MEDROXYPROGESTERONE acetate, 104mg/0.65ml, pref Uniject syr.

https://medicalguidelines.msf.org/en/node/865
https://unicat.msf.org/cat/product/75280
STD DINJMEDR6IP

Valid Article

Former Code(s): Z
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
22.1.2 - Injectable hormonal contraceptives
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AC06
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

MEDROXYPROGESTERONE, 104mg/0.65ml, syr. Uniject pref.

Full Name

Synonym: Sayana Press DMPA-SC®

Therapeutic Action

Long-acting synthetic progestogen

Sayana Press® contains 30% less depot medroxyprogesterone acetate (DMPA) than the intramuscular formulation of Depo-Provera® (DMPA-IM). Its efficacy, safety and speed of action are equivalent to DMPA-IM.

Indications

Self-administration of long-acting female contraception (3 months)

Sayana Press® does not replace DMPA-IM. It is an additional contraceptive option for relevant contexts.

Instructions for use

Uniject system (single-use, pre-filled injection system) containing 104 mg depot-medroxyprogesterone acetate (DMPA) in 0.65 ml of suspension.

The Uniject system comprises a pre-filled reservoir of DMPA, a valve (auto-disable feature), a needle port, a short 23G needle for SC injection and a needle cap.

Administer every 3 months by SC injection in the abdomen or upper thigh.

For instructions for use, see below. Contact your OC SRH advisor for more information on training package.

Image

Precautions for Use

Single use only

Do not administer by IM route.

Contraindicated during pregnancy.

Sayana Press® is suitable for community-based distribution and for women to administer themselves through self-injection. Self-administration should be initiated with the support of a healthcare professional. After proper training in injection technique and schedule of administration, patients may self-inject with Sayana Press® .

Storage

  • Below 25°C - Protect from sunlight
  • Do not refrigerate. Do not freeze.
  • Once open, use immediately. Discard any unused portion.
Image